| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/31/2001 | US6268179 A polynucleotide sequence; diagnosis and therapy of streptococci infections; treating conjunctivitis, pneumonia, meningitis, sinusitis, otitis media; screening antibiotics |
| 07/31/2001 | US6268172 A polynucleotide encoding a polypeptide for histidine kinase; screening and development of antibiotics for streptococcal diseases; otitis media, conjunctivitis, pneumonia, bacteremia pleural empyema, menegitis, sinusitis |
| 07/31/2001 | US6268171 Recombinant PilC proteins, methods for producing them and their use |
| 07/31/2001 | US6268165 Methods for the early diagnosis of ovarian cancer |
| 07/31/2001 | US6268138 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs |
| 07/31/2001 | US6268122 Synthetically generated polypeptide which display hepatitis viral antigenicity; for use in the detection of viral infection and vaccine preparation |
| 07/31/2001 | US6267967 Virus preparations and methods |
| 07/31/2001 | US6267966 Vaccine production of the Bacillus anthracis protective antigen |
| 07/31/2001 | US6267965 Vectors for insertion and expression of foreign genes for use as safe immunization vehicles to elicit immune response against poxvius-ctyomegalovirus and human cytomegalovirus |
| 07/31/2001 | US6267959 Monoclonal antibodies having property of causing apoptosis and used as anticancer agents |
| 07/31/2001 | US6267958 Lyophilized mixture of antibody which can be reconstituted with diluent to high protein concentration without loss of stability of protein; suitable for subcutaneous application |
| 07/31/2001 | CA2118119C Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 07/31/2001 | CA2107553C Monoclonal antibodies to stem cell factor receptors |
| 07/31/2001 | CA2055612C Oligonucleotidic sequences for the amplification of hiv-2 and siv-type retrovirus genome, and their applications for the in vitro diagnosis of infections due to these virus |
| 07/31/2001 | CA1341277C Anti-paratopic antibody and a method of its manufacture |
| 07/26/2001 | WO2001053487A2 Human sperm specific lysozyme-like proteins |
| 07/26/2001 | WO2001053486A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | WO2001053467A1 Recombinant flaviviruses and methods of use thereof |
| 07/26/2001 | WO2001053463A2 COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF HER-2/neu ASSOCIATED MALIGNANCIES |
| 07/26/2001 | WO2001053457A2 Vaccines against neurodegenerative disorders |
| 07/26/2001 | WO2001053353A2 Recombinant antibodies to human interkleukin-1 beta |
| 07/26/2001 | WO2001053352A2 Sperm specific proteins |
| 07/26/2001 | WO2001053351A2 Apoptin bindendes protein |
| 07/26/2001 | WO2001053349A2 Small cell lung cancer associated antigens and uses therefor |
| 07/26/2001 | WO2001053344A2 Chondromodulin-i related peptide |
| 07/26/2001 | WO2001053339A2 Egg specific surface proteins |
| 07/26/2001 | WO2001053334A1 thdF |
| 07/26/2001 | WO2001053297A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001052890A1 Heat shock/stress protein complexes as vaccines against neurodegenerative disorders |
| 07/26/2001 | WO2001052889A1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 07/26/2001 | WO2001052888A2 Improved dna vaccines for production-type animals |
| 07/26/2001 | WO2001052887A2 Vaccination against canine herpesvirus infection and vaccines |
| 07/26/2001 | WO2001052886A1 Prime-boost vaccination strategy |
| 07/26/2001 | WO2001052885A1 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
| 07/26/2001 | WO2001052884A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/26/2001 | WO2001052878A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 07/26/2001 | WO2001052877A1 Compositions and methods to treat neurodegenerative disorders |
| 07/26/2001 | WO2001052875A1 Vegf-d/vegf-c/vegf peptidomimetic inhibitor |
| 07/26/2001 | WO2001052874A2 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 07/26/2001 | WO2001052791A2 Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents |
| 07/26/2001 | WO2001052614A2 Selecting and producing t cell peptide epitopes |
| 07/26/2001 | WO2001018212A3 Mycobacterium paratuberculosis-specific antigens and their diagnostic uses |
| 07/26/2001 | WO2001017543A3 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 07/26/2001 | WO2001015726A3 Compositions for stimulating cytokine secretion and inducing an immune response |
| 07/26/2001 | WO2001014415A3 Egfh2 genes and gene products |
| 07/26/2001 | WO2001010902A8 Nucleoc acids and secreted polypeptides encoded thereby |
| 07/26/2001 | WO2001004148A9 Donor strand complemented pilin and adhesin broad-based vaccines |
| 07/26/2001 | WO2001000784A3 Compound derived from an offset orf of the ice gene |
| 07/26/2001 | WO2000075336A3 Polyepitopic proteinic fragments of e6 and e7 hpv proteins, production and use thereof in vaccines |
| 07/26/2001 | WO2000075180A3 Peptides for vaccinating against human cmv |
| 07/26/2001 | WO2000069915A3 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES |
| 07/26/2001 | WO2000066156A8 Death domain containing receptor 5 |
| 07/26/2001 | WO2000061613A9 Channel forming toxins as antiviral agents |
| 07/26/2001 | WO2000055194A9 Tuberculosis antigens and methods of use therefor |
| 07/26/2001 | WO2000040616A9 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/26/2001 | WO1999064040A8 Novel polyene macrolide compounds and uses |
| 07/26/2001 | US20010009959 Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies |
| 07/26/2001 | US20010009669 Inactive flavivirus such as tick-born encephalitis (TBE) virus, an immunogenic component bonded to the flavivirus or adsorbed therewith |
| 07/26/2001 | US20010009668 Enhancing immune response in animals |
| 07/26/2001 | US20010009667 Method of detecting nucleic acid encoding a retrovirus using polymerase chain reaction (pcr) |
| 07/26/2001 | US20010009666 Acellular pertussis vaccines and methods of preparation thereof |
| 07/26/2001 | CA2479511A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2479498A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2402831A1 Prime-boost vaccination strategy |
| 07/26/2001 | CA2398710A1 Egg specific surface proteins |
| 07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
| 07/26/2001 | CA2398102A1 Compounds and methods for prevention and treatment of her-2/neu associated malignancies |
| 07/26/2001 | CA2397896A1 Human sperm specific lysozyme-like proteins |
| 07/26/2001 | CA2397861A1 Vaccination against canine herpesvirosis and vaccines therefor |
| 07/26/2001 | CA2397838A1 Sperm specific proteins |
| 07/26/2001 | CA2397729A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/26/2001 | CA2397571A1 Apoptin-associating protein |
| 07/26/2001 | CA2397508A1 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
| 07/26/2001 | CA2397059A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes |
| 07/26/2001 | CA2396212A1 Recombinant antibodies to human interleukin-1 beta |
| 07/26/2001 | CA2395855A1 Recombinant flaviviruses and methods of use thereof |
| 07/26/2001 | CA2395736A1 Novel nucleic acids and polypeptides |
| 07/26/2001 | CA2365610A1 Compositions and methods for the treatment of tumor |
| 07/25/2001 | EP1118860A1 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1118334A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/25/2001 | EP1118331A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/25/2001 | EP1117842A1 Methods for selecting prostate cancer treatments and treating prostate cancer |
| 07/25/2001 | EP1117837A2 Methods and compositions for the diagnosis and therapy of prostate cancer |
| 07/25/2001 | EP1117835A1 Prevention of adhesions |
| 07/25/2001 | EP1117833A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 07/25/2001 | EP1117817A2 Therapeutically active proteins in plants |
| 07/25/2001 | EP1117807A2 Protective recombinant haemophilus influenzae high molecular weight proteins |
| 07/25/2001 | EP1117794A2 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 |
| 07/25/2001 | EP1117791A2 Cancer associated antigens and uses therefor |
| 07/25/2001 | EP1117788A1 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117784A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 07/25/2001 | EP1117783A1 Gene expressed in prostate cancer |
| 07/25/2001 | EP1117779A1 $i(MORAXELLA CATARRHALIS) PROTEIN, NUCLEIC ACID SEQUENCE AND USES THEREOF |
| 07/25/2001 | EP1117778A2 Methods and compositions for inducing differentiation and apoptosis in cells that overexpress the notch protein |
| 07/25/2001 | EP1117777A2 Shuffling of codon altered genes |
| 07/25/2001 | EP1117772A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 07/25/2001 | EP1117769A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 07/25/2001 | EP1117692A1 Tie2 agonist antibodies |